Lipoprotein(a) in Alzheimer, atherosclerotic, cerebrovascular, thrombotic, and valvular disease: mendelian randomization investigation.
File(s)CIRCULATIONAHA.120.045826.pdf (223.31 KB)
Published version
Author(s)
Type
Journal Article
Date Issued
2020-06-02
Date Acceptance
2020-06-01
Citation
Circulation, 2020, 141 (22), pp.1826-1828
ISSN
0009-7322
Publisher
American Heart Association
Start Page
1826
End Page
1828
Journal / Book Title
Circulation
Volume
141
Issue
22
Copyright Statement
© 2020 The Authors. Circulation is
published on behalf of the American
Heart Association, Inc., by Wolters
Kluwer Health, Inc. This is an open
access article under the terms of the
Creative Commons Attribution License,
which permits use, distribution, and
reproduction in any medium, provided
that the original work is properly cited.
published on behalf of the American
Heart Association, Inc., by Wolters
Kluwer Health, Inc. This is an open
access article under the terms of the
Creative Commons Attribution License,
which permits use, distribution, and
reproduction in any medium, provided
that the original work is properly cited.
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/32479194
Subjects
Alzheimer disease
Mendelian randomization analysis
atherosclerosis
heart valve diseases
lipoprotein(a)
stroke
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2020-06-01